Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
27,02 USD | -1,12% | -2,03% | -27,27% |
Attività
Numero di dipendenti: 565
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Fertility Benefit Services
62,1
%
| 510 | 64,8 % | 676 | 62,1 % | +32,57% |
Pharmacy Benefit Services
37,9
%
| 277 | 35,2 % | 412 | 37,9 % | +48,97% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 787 | 100,0 % | 1 089 | 100,0 % | +38,34% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Peter Anevski
CEO | Chief Executive Officer | 56 | 01/01/17 |
Michael Sturmer
PSD | President | 47 | 01/03/21 |
Mark Livingston
DFI | Director of Finance/CFO | 58 | 01/05/19 |
David Schlanger
CHM | Chairman | 64 | 16/12/16 |
Janet Choi
CTO | Chief Tech/Sci/R&D Officer | - | 04/04/23 |
Alan Copperman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/17 |
James T. Hart
IRC | Investor Relations Contact | - | 01/07/19 |
Allison Swartz
LAW | General Counsel | 35 | 28/11/22 |
Julie Stadlbauer
PRN | Corporate Officer/Principal | - | - |
Cassandra Pratt
HRO | Human Resources Officer | - | 01/03/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 01/05/10 |
Kevin Gordon
BRD | Director/Board Member | 61 | 01/10/19 |
Norman Payson
BRD | Director/Board Member | 49 | 16/12/16 |
Roger Holstein
BRD | Director/Board Member | 71 | 16/11/20 |
Fred Cohen
BRD | Director/Board Member | 67 | 01/03/15 |
Lloyd Dean
BRD | Director/Board Member | 73 | 30/08/22 |
Cheryl Scott
BRD | Director/Board Member | 74 | 01/10/19 |
Jeffrey Park
BRD | Director/Board Member | 52 | 01/10/19 |
Peter Anevski
CEO | Chief Executive Officer | 56 | 01/01/17 |
David Schlanger
CHM | Chairman | 64 | 16/12/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 96 560 245 | 82 565 080 ( 85,51 %) | 1 339 557 ( 1,387 %) | 85,51 % |
Coordinate società
Settore
Vendite per attività
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-27,27% | 2,6 Mrd | |
+13,26% | 125 Mrd | |
+11,08% | 94,92 Mrd | |
-21,81% | 43,15 Mrd | |
-7,56% | 36,81 Mrd | |
-15,21% | 18,06 Mrd | |
-4,18% | 1,55 Mrd | |
+17,63% | 511 Mln |
- Borsa valori
- Azioni
- Azione PGNY
- Società Progyny, Inc.